PDF
Published
2026-05-12
Issue
Section
Pharmacy Practice & Practice-Based Research
Categories
License
Copyright (c) 2026 Michael J. Schuh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of content published in INNOVATIONS in pharmacy belongs to the author(s).
Pharmacogenomic considerations in a pretransplant statin tolerant, post-transplant intolerant liver transplant patient: A case report
Michael J. Schuh
Mayo School of Health Related Sciences
https://orcid.org/0000-0003-0524-746X
DOI: https://doi.org/10.24926/iip.v17i1.6824
Keywords: liver transplant, pharmacogenomics, PGx, statin therapy, myalgias
Abstract
As pharmacogenomics testing is becoming more common, it can be used in more medical settings to assist in clinical decision making. This is a case study examining the implications of a patient having potentially different cytochrome P-450 enzyme phenotypes in the donor liver once transplanted. This patient tolerated statin therapy prior to liver transplantation but was intolerant to the same statin after liver transplant.
